Animal study · rats

MOTS-c eased lung ischemia-reperfusion injury and deaths in rats

Checked against the paper Animal studyPublished by PepVault

The takeaway

This adds rat evidence that MOTS-c can lessen lung damage when blood flow returns after being cut off, plus early patient data using it only as a warning marker after bypass surgery, not as a treatment.

Kind
Animal study
Studied in
Rats
Published
2025
Journal
Redox Biol

What they tested

The team asked whether MOTS-c protects the lung from ischemia-reperfusion injury, damage when blood flow is cut off and then restored, and whether blood MOTS-c levels can predict lung failure after heart-lung bypass surgery.

How the study was done

A preclinical study in rat models of lung ischemia-reperfusion injury, with lab work on cells exposed to low oxygen and then oxygen again. It also measured blood MOTS-c in patients during the first 24 h after cardiopulmonary bypass (a heart-lung machine used in surgery).

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking MOTS-c? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In rats, MOTS-c given as a treatment reduced lung injury, oxidative damage (harm from reactive oxygen molecules), inflammation and deaths. In the rat models, endothelial cells, the cells lining blood vessels, raised their own MOTS-c the most, and this tracked with a better-kept lung barrier and less oxidative stress. In patients, the rise in blood MOTS-c within 24 h after bypass predicted ARDS (acute respiratory distress syndrome, a severe form of lung failure) better than standard markers. Prediction models that included this rise reached an AUC of 0.885, where AUC scores how well a test separates people who get ARDS from those who don't.

What it doesn’t show

MOTS-c was tested as a treatment only in rats, so the protective effect is not a human result. The patient part only used MOTS-c as a blood marker to predict risk, and the 0.885 score came from models that combined it with other factors.

The paper

Li et al. MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genes. Redox Biol. 2025.

The compound

More studies on MOTS-c

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking MOTS-c? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo